Recurrence-free survival prediction for anal squamous cell carcinoma after chemoradiotherapy using planning CT-based radiomics model
British Journal of Radiology · 2025
DOI: 10.1093/bjr/tqae235 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Radiology, 2025. Verfasst von Shanshan Tang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, 75235, United States. Hauptthemen laut MEDLINE: Anus Neoplasms, Chemoradiotherapy, Carcinoma, Squamous Cell, Tomography, X-Ray Computed. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Objectives
Approximately 30% of non-metastatic anal squamous cell carcinoma (ASCC) patients will experience recurrence after chemoradiotherapy (CRT), and currently available clinical variables are poor predictors of treatment response. We aimed to develop a model leveraging information extracted from radiation pretreatment planning CT to predict recurrence-free survival (RFS) in ASCC patients after CRT.
Methods
Radiomics features were extracted from planning CT images of 96 ASCC patients. Following pre-feature selection, the optimal feature set was selected via step-forward feature selection with a multivariate Cox proportional hazard model. The RFS prediction was generated from a radiomics-clinical combined model based on an optimal feature set with 5 repeats of nested 5-fold cross validation. The risk stratification ability of the proposed model was evaluated with Kaplan-Meier analysis.
Results
Shape- and texture-based radiomics features significantly predicted RFS. Compared to a clinical-only model, radiomics-clinical combined model achieves better performance in the testing cohort with higher concordance index (0.80 vs 0.73) and AUC (0.84 vs 0.78 for 1-year RFS, 0.84 vs 0.79 for 2-year RFS, and 0.85 vs 0.81 for 3-year RFS), leading to distinctive high- and low-risk of recurrence groups (P < .001).
Conclusions
A treatment planning CT based radiomics and clinical combined model had improved prognostic performance in predicting RFS for ASCC patients treated with CRT as compared to a model using clinical features only. Advances in knowledge The use of radiomics from planning CT is promising in assisting in personalized management in ASCC. The study outcomes support the role of planning CT-based radiomics as potential imaging biomarker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, 75235, United States.
- Medical Artificial Intelligence and Automation Laboratory, University of Texas Southwestern Medical Center, Dallas, TX, 75235, United States.
ORCID-Profile: Shanshan Tang, Jing Wang
Förderung
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Tang, S., Wang, K., Hein, D., Lin, G., Sanford, N. N., & Wang, J. (2025). Recurrence-free survival prediction for anal squamous cell carcinoma after chemoradiotherapy using planning CT-based radiomics model. British Journal of Radiology. https://doi.org/10.1093/bjr/tqae235
Vancouver
Tang S, Wang K, Hein D, Lin G, Sanford NN, Wang J. Recurrence-free survival prediction for anal squamous cell carcinoma after chemoradiotherapy using planning CT-based radiomics model. British Journal of Radiology. 2025. doi:10.1093/bjr/tqae235
BibTeX
@article{Tang2025,
author = {Tang, Shanshan and Wang, Kai and Hein, David and Lin, Gloria and Sanford, Nina N and Wang, Jing},
title = {Recurrence-free survival prediction for anal squamous cell carcinoma after chemoradiotherapy using planning CT-based radiomics model},
journal = {British Journal of Radiology},
year = {2025},
doi = {10.1093/bjr/tqae235}
}
EUVIMED